These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31389664)

  • 1. New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections.
    De Clercq E
    Chem Asian J; 2019 Nov; 14(22):3962-3968. PubMed ID: 31389664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curious (Old and New) Antiviral Nucleoside Analogues with Intriguing Therapeutic Potential.
    De Clercq E
    Curr Med Chem; 2015; 22(34):3866-80. PubMed ID: 26112146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.
    Westover JB; Sefing EJ; Bailey KW; Van Wettere AJ; Jung KH; Dagley A; Wandersee L; Downs B; Smee DF; Furuta Y; Bray M; Gowen BB
    Antiviral Res; 2016 Feb; 126():62-8. PubMed ID: 26711718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking.
    Silva Arouche TD; Reis AF; Martins AY; S Costa JF; Carvalho Junior RN; J C Neto AM
    J Nanosci Nanotechnol; 2020 Dec; 20(12):7311-7323. PubMed ID: 32711596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus.
    Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Garza NL; Donnelly G; Cazares LH; Soloveva V; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
    Antiviral Res; 2018 Mar; 151():50-54. PubMed ID: 29289664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Nucleosides To Be Revisited.
    De Clercq E
    J Med Chem; 2016 Mar; 59(6):2301-11. PubMed ID: 26513594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses.
    Madelain V; Guedj J; Mentré F; Nguyen TH; Jacquot F; Oestereich L; Kadota T; Yamada K; Taburet AM; de Lamballerie X; Raoul H
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27736754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.
    Madelain V; Nguyen TH; Olivo A; de Lamballerie X; Guedj J; Taburet AM; Mentré F
    Clin Pharmacokinet; 2016 Aug; 55(8):907-23. PubMed ID: 26798032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2.
    Simonis A; Theobald SJ; Fätkenheuer G; Rybniker J; Malin JJ
    EMBO Mol Med; 2021 Jan; 13(1):e13105. PubMed ID: 33015938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New nucleoside analogues for chronic hepatitis B.
    Schalm SW; Wolters LM; van Nunen AB; Niesters HG; de Man RA
    Acta Gastroenterol Belg; 2000; 63(2):191-3. PubMed ID: 10925461
    [No Abstract]   [Full Text] [Related]  

  • 11. Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.
    Madelain V; Duthey A; Mentré F; Jacquot F; Solas C; Lacarelle B; Vallvé A; Barron S; Barrot L; Mundweiler S; Thomas D; Carbonnelle C; Raoul H; de Lamballerie X; Guedj J
    Antiviral Res; 2020 May; 177():104758. PubMed ID: 32135218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice.
    Eyer L; Nougairède A; Uhlířová M; Driouich JS; Zouharová D; Valdés JJ; Haviernik J; Gould EA; De Clercq E; de Lamballerie X; Ruzek D
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31142664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad-Spectrum Antiviral Strategies and Nucleoside Analogues.
    Geraghty RJ; Aliota MT; Bonnac LF
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33924302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleoside analogues for chronic hepatitis B.
    Wolters LM; Niesters HG; de Man RA
    Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1499-506. PubMed ID: 11742201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
    Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
    J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models.
    Wang Y; Li P; Rajpoot S; Saqib U; Yu P; Li Y; Li Y; Ma Z; Baig MS; Pan Q
    Sci Rep; 2021 Dec; 11(1):23465. PubMed ID: 34873274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. l-like 3-deazaneplanocin analogues: Synthesis and antiviral properties.
    Chen Q; Smith A
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126613. PubMed ID: 31431358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers.
    Malvy D; Taburet AM; de Lamballerie X; Mentre F; Extramiana F
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008259. PubMed ID: 32584817
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir.
    Tchesnokov EP; Feng JY; Porter DP; Götte M
    Viruses; 2019 Apr; 11(4):. PubMed ID: 30987343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.